Search Results for "activate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for activate. Results 811 to 820 of 1334 total matches.

Cannabis and Cannabinoids

   
The Medical Letter on Drugs and Therapeutics • Nov 18, 2019  (Issue 1585)
Cannabis and Cannabinoids Cannabis (marijuana) contains more than 60 pharmacologically active ...
Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce intoxication or euphoria.
Med Lett Drugs Ther. 2019 Nov 18;61(1585):179-82 |  Show IntroductionHide Introduction

Drugs for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Jul 08, 2024  (Issue 1706)
. BISPHOSPHONATES — These nonhormonal drugs decrease bone resorption by binding to active sites of bone remodeling ...
Pharmacologic treatment is recommended for postmenopausal women who have bone density T-scores (standard deviations from normal mean values in the spine, femoral neck, total hip, or distal radius) of -2.5 or below, T-scores between -1.0 and -2.5 with a history of fragility (low-trauma) fracture of the hip or spine, or T-scores between -1.0 and -2.5 with a FRAX 10-year probability of ≥3% for hip fracture or ≥20% for major osteoporotic fracture.
Med Lett Drugs Ther. 2024 Jul 8;66(1706):105-12   doi:10.58347/tml.2024.1706a |  Show IntroductionHide Introduction

Methylphenidate Revisited

   
The Medical Letter on Drugs and Therapeutics • May 06, 1988  (Issue 765)
of motor activity, impulsivity, and inattention; boys are affected more often than girls (R McGee et al, J ...
Methylphenidate (Ritalin and others), a Schedule II controlled substance in the USA, is a short-acting central-nervous-system stimulant widely used for treatment of children with school performance or behavior problems, or what is now called Attention Deficit-Hyperactivity Disorder, or AD-HD (American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, third ed., revised [DSM-III R], Washington, DC:authors, 1987, p 50). Some studies have estimated that more than 3% of elementary school students are taking methylphenidate, and one parents' group has brought a...
Med Lett Drugs Ther. 1988 May 6;30(765):51-2 |  Show IntroductionHide Introduction

Etidronate for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Dec 14, 1990  (Issue 833)
doses of bisphosphonates adsorb to apatite crystals, inhibiting the activity of osteoclasts ...
Etidronate (e ti droe' nate) disodium (Didronel - Norwich Eaton), an oral bisphosphonate available for many years for treatment of Paget's disease (Medical Letter, 20:78, 1978), recently has also been used for treatment of postmenopausal osteoporosis.
Med Lett Drugs Ther. 1990 Dec 14;32(833):111-4 |  Show IntroductionHide Introduction

Gallium For Hypercalcemia of Malignancy

   
The Medical Letter on Drugs and Therapeutics • May 03, 1991  (Issue 843)
in Europe. MECHANISM OF ACTION — Animal and in vitro studies indicate that gallium acts at sites of active ...
Gallium nitrate (Ganite - Fujisawa, USA), originally an anticancer drug, was recently marketed for treatment of cancer-associated hypercalcemia that has not responded to hydration. Other drugs used for treatment of hypercalcemia include furosemide (Lasix, and others), the bisphosphonate etidronate (Didronel IV), calcitonin (Calcimar), and plicamycin (Mithracin, formerly mithramycin) (RAB Schaiff et al, Clin Pharm, 8:108, 1989). Newer bisphosphonates are available in Europe.
Med Lett Drugs Ther. 1991 May 3;33(843):41-2 |  Show IntroductionHide Introduction

Intranasal Triamcinolone For Allergic Rhinitis

   
The Medical Letter on Drugs and Therapeutics • Dec 13, 1991  (Issue 859)
more active topically than intranasal dexamethasone and less likely to cause systemic effects (Medical ...
An intranasal formulation of the corticosteroid triamcinolone (Nasacort - Rh ne- Poulenc Rorer) was recently approved by the US Food and Drug Administration for once-daily treatment of seasonal and perennial allergic rhinitis.
Med Lett Drugs Ther. 1991 Dec 13;33(859):116-7 |  Show IntroductionHide Introduction

Pravastatin, Simvastatin, and Lovastatin For Serum Cholesterol Concentrations

   
The Medical Letter on Drugs and Therapeutics • Jun 12, 1992  (Issue 872)
aminotransferase activities to more than three times normal occurs in 1% to 2% of patients taking higher doses ...
Pravastatin - Bristol-Myers Squibb) and simvastatin (Zocor -Merck), two new inhibitors of cholesterol synthesis similar to lovastatin (Mevacor - Merck), have now been marketed in the USA for treatment of hypercholesterolemia. Lovastatin (Medical Letter, 29:99, 1987) is the most frequently prescribed of all cholesterol-lowering drugs in the USA. Pravastatin and simvastatin were previously reviewed in The Medical Letter when they became available in Canada (volume 33, page 18, 1991).
Med Lett Drugs Ther. 1992 Jun 12;34(872):57-8 |  Show IntroductionHide Introduction

Atovaquone for Pneumocystis Carinii Pneumonia

   
The Medical Letter on Drugs and Therapeutics • Apr 02, 1993  (Issue 893)
interferes with mitochondrial electron transfer in Pneumocystis carinii. It is also active against ...
Atovaquone (Mepron - Burroughs Wellcome), a hydroxynaphthoquinone, was recently approved by the US Food and Drug Administration (FDA) for oral treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in patients who cannot tolerate trimethoprim-sulfamethoxazole (Septra, Bactrim, and others). PCP is a common opportunistic infection and frequent cause of death in patients with AIDS.
Med Lett Drugs Ther. 1993 Apr 2;35(893):28-9 |  Show IntroductionHide Introduction

Ketorolac for Seasonal Allergic Conjunctivitis

   
The Medical Letter on Drugs and Therapeutics • Sep 17, 1993  (Issue 905)
inflammation and ocular itching, but the decrease was greater with the active drug (Z Ballas et al, Surv ...
Ketorolac (kee' toe role ak) tromethamine 0.5%, a nonsteroidal anti-inflammatory drug (NSAID) previously available for parenteral and oral administration (Toradol - Medical Letter, 32:79, 1990), has now been approved for ophthalmic use (Acular - Allergan, Fisons) to relieve itching in seasonal allergic conjunctivitis. NSAIDs decrease prostaglandin concentrations in the eye, which theoretically might contribute to a decrease in itching. Several other NSAIDs are available for ophthalmic use in the USA, but none is marketed for this indication. Flurbiprofen (Ocufen) and suprofen (Profenal) ...
Med Lett Drugs Ther. 1993 Sep 17;35(905):88-9 |  Show IntroductionHide Introduction

Risperidone for Chronic Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Apr 15, 1994  (Issue 920)
in the liver by cytochrome P 450 IID 6 enzymes. In most patients (except poor metabolizers), an active ...
Risperidone (Risperdal - Janssen), a benzisoxazole derivative, is now available in the USA for treatment of schizophrenia and other psychotic disorders.
Med Lett Drugs Ther. 1994 Apr 15;36(920):33-4 |  Show IntroductionHide Introduction